Sinus Bradycardia in a Pediatric Patient Treated With Remdesivir for Acute Coronavirus Disease 2019: A Case Report and a Review of the Literature.
J Pediatric Infect Dis Soc
; 10(9): 926-929, 2021 Oct 27.
Article
en En
| MEDLINE
| ID: mdl-34173663
Remdesivir is an RNA polymerase inhibitor that is commonly used in the treatment of patients with severe acute coronavirus disease 2019 (COVID-19). As the severe acute respiratory syndrome coronavirus 2 spreads, the use of remdesivir is likely to increase. Most of the patients treated with remdesivir will not experience any adverse events although some side effects have been reported. Here, we describe a case of sinus bradycardia associated with remdesivir therapy in a pediatric patient with severe acute COVID-19.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Tratamiento Farmacológico de COVID-19
Límite:
Child
/
Humans
Idioma:
En
Revista:
J Pediatric Infect Dis Soc
Año:
2021
Tipo del documento:
Article
País de afiliación:
Estados Unidos